Nephrotoxicity of amphotericin B administered to dogs in a fat emulsion versus five percent dextrose solution

American Journal of Veterinary Research

Volumn 57, Issue 7, 1996, Pages 1054-1058

  Randall, Stacy R ^a,b   Adams, Larry G ^a   White, M Randall ^a   DeNicola, Dennis B ^a  

^a PURDUE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLUCOSE; INTRALIPID; LIPID EMULSION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG FORMULATION; MALE; NEPHROTOXICITY; NONHUMAN;

AMPHOTERICIN B; ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD CELL COUNT; BLOOD UREA NITROGEN; CREATININE; DOGS; EMULSIONS; GLUCOSE; KIDNEY; MALE; POTASSIUM; SOLUTIONS; TIME FACTORS;

EID: 0030037054     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Noxon JO. Systemic antifungal chemotherapy. In: Kirk RW, ed. Current veterinary therapy K. 10th ed. Philadelphia: WB Saunders Co, 1989;1101-1106.
2. Rubin SI. Nephrotoxicity of amphotericin B. In: Kirk RW, ed. Current veterinary therapy IX. 9th ed. Philadelphia: WB Saunders Co, 1986;1142-1146.
3. Rubin SI, Krawiec DR, Gelberg H, et al. Nephrotoxicity of amphotericin B in dogs comparison of two methods of administration. Can J Vet Res 1989;53:23-28.
4. Green CA. Antifungal chemotherapy. In: Green CA, ed. Infectious disease of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1990;649-658.
5. Wolf AM. Deep mycotic infections. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. 3rd ed. Philadelphia: WB Saunders Co, 1989;341-372.
6. Legendre AM. Itraconazole: a new antifungal drug. In: Proceedings of the eleventh ACVIM forum. Washington, DC: American College of Veterinary Internal Medicine, 1993;277-278.
7. Legendre AM. Antimycotic drug therapy. In: Kirk RW, ed. Current veterinary therapy XII. 12th ed. Philadelphia: WB Saunders Co, 1995;328-331.
8. Bernard MA, Jacobs DO, Rombeau JL. Nutritional and metabolic support of hospitalized patients. Philadelphia: WB Saunders Co, 1986:97-100.
9. Nichols AJ, Koster PF, Brooks DP, et al. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin D in the dog. J Pharmacol Exp Ther 1992;260:269-274.
10. Gerkins JF, Branch RA. Influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity. J Pharmacol Exp Ther 1980;214:306-311.
11. Gerkins JF, Heidemann HT, Jackson EK, et al. Effect of aminophylline on amphotericin B nephrotoxicity in the dog. J Pharmacol Exp Ther 1983;244:609-613.
12. Joly V, Dromer F, Barge J, et al. Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits. J Pharmacol Exp Ther 1989;251:311-316.
13. Proffitt R, Satorius A, Chiang S, et al. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991;28:49-61.
14. Tollemar J, Anderssonn S, Ringden O, et al. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Mycoses 1992;35:215-220.
15. Brajtburg J, Powderly WG, Kobayashi GS, et al. Amphotericin B: delivery systems. Antimicrob Agents Chemother 1990;34:381-384.
16. Joly V, Bolard J, Saint Julien L, et al. Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations. Antimicrob Agents Chemother 1992;36: 262-266.
17. Moreau P, Milpied N, Fayette N, et al. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother 1992;30:535-541.
18. Kirsh R, Goldstein R, Tarloff J, et al. An emulsion of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis 1988;158:1065-1070.
19. Chavanet PY, Garry I, Charlier N, et al. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. Br Med J 1992;305:921-925.
20. Finco DR, Tabaru H, Brown SA, et al. Endogenous creatinine clearance measurement of glomerular filtration rate in dogs. Am J Vet Res 1993;54:1575-1578.
21. Chew DJ, Dibartola SP. Diagnosis and pathophysiology of renal disease. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. 3rd ed. Philadelphia: WB Saunders Co, 1989;1893-1961.
22. Hoeprich PD, Huston AC, Wolfe BM. Toxicity of amphotericins on chronic administration to mongrel dogs. Diagn Microbiol Infect Dis 1985;3:47-58.
23. Hakansson I. Experience in long term studies on nine intravenous fat emulsions in dogs. Nutr Dieta 1968;10:54-76.
24. Hakansson I. Effects in dogs of two fat emulsions for intravenous nutrition. Nutr Dieta 1965;7:90-102.